AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms

por Beitzen-Heineke, Antonia, Berenbrok, Nikolaus, Waizenegger, Jonas, Paesler, Sarina, Gensch, Victoria, Udonta, Florian, Vargas Delgado, Maria Elena, Engelmann, Janik, Hoffmann, Friederike, Schafhausen, Philippe, von Amsberg, Gunhild, Riecken, Kristoffer, Beumer, Niklas, Imbusch, Charles D., Lorens, James, Fischer, Thomas, Pantel, Klaus, Bokemeyer, Carsten, Ben-Batalla, Isabel, Loges, Sonja
Publicado 2021